DexCom, Inc. Stock price

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 03:59:59 2024-03-28 pm EDT 5-day change 1st Jan Change
138.7 USD -0.57% Intraday chart for DexCom, Inc. +3.95% +11.76%
Sales 2024 * 4.33B Sales 2025 * 5.15B Capitalization 53.77B
Net income 2024 * 673M Net income 2025 * 882M EV / Sales 2024 * 12.8 x
Net Debt 2024 * 1.51B Net Debt 2025 * 980M EV / Sales 2025 * 10.6 x
P/E ratio 2024 *
83.8 x
P/E ratio 2025 *
65.1 x
Employees 9,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.18%
1 week+4.40%
Current month+21.04%
1 month+21.94%
3 months+12.18%
6 months+45.90%
Current year+12.24%
More quotes
1 week
131.36
Extreme 131.36
142.00
1 month
113.69
Extreme 113.69
142.00
Current year
113.05
Extreme 113.05
142.00
1 year
74.75
Extreme 74.75
142.00
3 years
66.89
Extreme 66.8925
164.86
5 years
26.86
Extreme 26.86
164.86
10 years
7.02
Extreme 7.0225
164.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 07-10-31
Director of Finance/CFO 44 18-08-31
Chief Tech/Sci/R&D Officer 47 22-09-30
Members of the board TitleAgeSince
Director/Board Member 65 09-11-19
Director/Board Member 63 14-11-18
Director/Board Member 69 09-07-08
More insiders
Date Price Change Volume
24-03-28 138.7 -0.57% 2 473 078
24-03-27 139.5 -0.32% 2,031,775
24-03-26 139.9 -0.12% 3,096,190
24-03-25 140.1 +5.20% 3,917,443
24-03-22 133.2 -0.17% 1,426,253

Delayed Quote Nasdaq, March 28, 2024 at 01:16 pm EDT

More quotes
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
139.5 USD
Average target price
147.2 USD
Spread / Average Target
+5.54%
Consensus
  1. Stock
  2. Equities
  3. Stock DexCom, Inc. - Nasdaq